AI chatbots are used in many ways in healthcare—from scheduling appointments to giving medical advice—but because they are built differently and tested in different ways, it's hard to know which ones work best or for whom.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review with subgroup analysis could determine whether certain chatbot types (e.g., generative vs. rule-based) or use cases (e.g., mental health vs. scheduling) consistently yield better outcomes across standardized metrics.
A systematic review and meta-analysis of RCTs comparing generative AI chatbots versus rule-based chatbots in managing chronic conditions, using standardized outcome measures (e.g., adherence rates, satisfaction scores, staff time saved) across at least 25 trials with clear intervention descriptions and validated tools.
An RCT could determine whether a specific type of AI chatbot (e.g., generative model for diabetes education) produces different outcomes than another type (e.g., rule-based reminder system) under identical conditions.
A double-blind RCT with 200 adults with type 2 diabetes, randomized to either a generative AI chatbot delivering personalized dietary advice based on glucose logs, or a rule-based chatbot delivering fixed educational messages, both used daily for 12 weeks, measuring HbA1c change and patient satisfaction (CSQ-8) as primary outcomes.
A cohort study could track whether different chatbot implementations (e.g., hospital vs. clinic, text vs. voice) lead to different patterns of adoption, satisfaction, or efficiency over time.
A prospective cohort study following 1,000 patients across 15 healthcare settings using different AI chatbot types (generative, retrieval, hybrid) for chronic disease support, measuring adoption rates, user engagement frequency, satisfaction scores, and staff time saved over 12 months, adjusting for setting and patient demographics.
A cross-sectional survey could estimate the distribution of chatbot types and functions currently in use across healthcare systems.
A national cross-sectional survey of 500 healthcare institutions in the U.S. and EU, asking for detailed descriptions of AI chatbot type (rule-based, retrieval, generative), primary function (scheduling, education, triage), integration method, and evaluation metrics used.
A case series could document novel or unusual implementations of AI chatbots in niche clinical contexts.
A case series of 10 healthcare institutions using AI chatbots in unconventional ways (e.g., for end-of-life communication, rare disease support, multilingual patient triage), documenting design choices, implementation challenges, and perceived outcomes.